CD4 and myeloid sarcoma: The shared clinical and histopathological features of EAE and MS suggest that both are autoimmune diseases induced by CNS-specific CD4+ autoreactive major histocompatibility complex class II (MHC-II) restricted T cells, which trigger a cascade of pathogenic events resulting in inflammation, demyelination, and neurodegeneration (19).